Nonlesional sources of contrast enhancement on postgadolinium “Black-Blood” 3D T1-SPACE images in patients with multiple sclerosis

L Danieli, L Roccatagliata… - American Journal …, 2022 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: We hypothesized that 3D T1-TSE “black-blood” images
may carry an increased risk of contrast-enhancing lesion misdiagnosis in patients with MS …

An initiative to reduce unnecessary gadolinium-based contrast in multiple sclerosis patients

JD Rudie, RR Mattay, M Schindler, S Steingall… - Journal of the American …, 2019 - Elsevier
Objective Patients with multiple sclerosis (MS) routinely undergo serial contrast-enhanced
MRIs. Given concerns regarding tissue deposition of gadolinium-based contrast agents …

Evaluation of leptomeningeal contrast enhancement using pre-and postcontrast subtraction 3D-FLAIR imaging in multiple sclerosis

R Zivadinov, DP Ramasamy… - American Journal …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Leptomeningeal contrast enhancement is found in
patients with multiple sclerosis, though reported rates have varied. The use of 3D-fluid …

[HTML][HTML] Fluid and white matter suppression: new sensitive 3 T magnetic resonance imaging contrasts for cortical lesion detection in multiple sclerosis

J Müller, F La Rosa, J Beaumont, C Tsagkas… - Investigative …, 2022 - journals.lww.com
Objective Cortical lesions are common in multiple sclerosis (MS), but their visualization is
challenging on conventional magnetic resonance imaging. The uniform image derived from …

Multiple sclerosis: prevalence of the 'central vein'sign in white matter lesions on gadolinium-enhanced susceptibility-weighted images

G Sparacia, F Agnello, A Iaia, A Banco… - The Neuroradiology …, 2021 - journals.sagepub.com
Aims To evaluate prospectively whether an intravenous gadolinium injection could improve
the detection of the central vein sign on susceptibility-weighted imaging sequences obtained …

Is Gadolinium-based contrast material needed for MRI follow-up of multiple sclerosis?

AM Saindane - Radiology, 2019 - pubs.rsna.org
Radiology: Volume 291: Number 2—May 2019 n radiology. rsna. org 437 know if they are
benefiting a patient and if their risk is worth the continued cost. The rate of contrast …

[HTML][HTML] T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis

C Thaler, T Schneider, J Sedlacik, D Kutzner… - PLoS …, 2017 - journals.plos.org
Purpose In multiple sclerosis (MS) the sensitivity for detection of contrast enhancing lesions
(CEL) in T1-weighted scans is essential for diagnostics and therapy decisions. The purpose …

Do all patients with multiple sclerosis benefit from the use of contrast on serial follow-up MR imaging? A retrospective analysis

RR Mattay, K Davtyan, M Bilello… - American Journal of …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Patients with multiple sclerosis routinely have MR imaging
with contrast every 6–12 months to assess response to medication. Multiple recent studies …

Limited utility of gadolinium contrast administration in routine multiple sclerosis surveillance

G Johnston, T Johnson, AJ Solomon… - Journal of …, 2021 - Wiley Online Library
ABSTRACT BACKGROUND AND PURPOSE Assess the incidence of enhancing lesions on
follow‐up MRIs in patients with multiple sclerosis (MS) to determine the utility of intravenous …

Accuracy of unenhanced MRI in the detection of new brain lesions in multiple sclerosis

P Eichinger, S Schön, V Pongratz, H Wiestler, H Zhang… - Radiology, 2019 - pubs.rsna.org
Background Administration of a gadolinium-based contrast material is widely considered
obligatory for follow-up imaging of patients with multiple sclerosis (MS). However, advances …